China, Sept. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prediction of CK19 expression and prognostic risk for postoperative hepatocellular carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133425
Registration Time: 2026/09/28
Type: Observational study
Primary Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343499
Published by HT Digital Content Services with permission from Health Daily Digest....